Atea Pharmaceuticals's total assets for Q3 2025 were $342.96M, a decrease of -12.42% from the previous quarter. AVIR total liabilities were $27.18M for the fiscal quarter, a -0.02% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.